View in EDS HTML Full Text PDF Full Text

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.
Authors: Biederstädt A; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany., Bassermann F; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Hecker JS; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.
Source: Frontiers in immunology [Front Immunol] 2025 Jul 08; Vol. 16, pp. 1585556. Date of Electronic Publication: 2025 Jul 08 (Print Publication: 2025).
Publication Type: Journal Article; Systematic Review; Meta-Analysis
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40698082
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Biederstädt+A%22">Biederstädt A</searchLink>; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Bassermann+F%22">Bassermann F</searchLink>; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Hecker+JS%22">Hecker JS</searchLink>; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Jul 08; Vol. 16, pp. 1585556. <i>Date of Electronic Publication: </i>2025 Jul 08 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review; Meta-Analysis
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40698082
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1585556
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1585556
    Titles:
      – TitleFull: Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Biederstädt A
      – PersonEntity:
          Name:
            NameFull: Bassermann F
      – PersonEntity:
          Name:
            NameFull: Hecker JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 07
              Text: 2025 Jul 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1